Intelliject to be recognized with George DiDomizio Industry Award

The Institute for Safe Medication Practices (ISMP) has announced that this year's George DiDomizio Industry Award is being presented to Intelliject, Inc. for pioneering advances in drug/device combination products with the Auvi-Q™ epinephrine auto-injector (also known as Allerject™ in Canada). Auvi-Q is the first auto-injector with audio as well as visual cues for the emergency treatment of life-threatening allergic reactions.

"ISMP does a wonderful job raising awareness and educating both healthcare professionals and the public in order to reduce medication errors. We are honored they are recognizing Auvi-Q and Intelliject," said Mark Licata, Vice President of Industrialization and Quality at Intelliject, and co-inventor of the Auvi-Q.

"With more and more healthcare delivery happening outside the direct supervision of healthcare professionals, there is increasing emphasis on the usability of drug/device combination products," continued Licata.  "This award is tangible recognition for the way we have sought to understand and address patient needs."

The George DiDomizio Industry Award is part of the 16^th annual ISMP Cheers Awards, which are presented to individuals, organizations, and companies that have set a standard of excellence for others to follow in the prevention of medication errors and adverse drug events. Mr. Licata will accept the award on Intelliject's behalf during a ceremony on December 10 in Orlando, FL.